title: [Treatment of gout in patients with chronic kidney disease].
abstract: Hyperuricemia and its clinical manifestations, such as gout, are frequently encountered in patients with chronic renal disease and renal transplants. Usual treatments are either contraindicated or are prone to side-effects in these patients. Presently, there is no clear concensus regarding therapeutic guidelines of hyperuricemia and gout in this subset of patients. Steroids remain the more effective and safer treatment in absence of superimposed infection. Though allopurinol is not recommended for prophylaxis of hyperuricemia, this drug is still the cornerstone in the treatment of patients suffering from gout and is rather well tolerated when posology is adapted.
authors.affiliation: Service de médecine interne générale, HUG, 1211 Genève 14.
authors.forename: J
authors.initials: J
authors.lastname: Bertrand
authors.forename: S
authors.initials: S
authors.lastname: Genevay
authors.forename: P
authors.initials: P
authors.lastname: Saudan
mesh_terms: D002908:Chronic Disease; D006073:Gout / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D033461:Hyperuricemia / Q000150:complications / Q000188:drug therapy; D007674:Kidney Diseases / Q000150:complications*